Ac-EDIIRNIARHLAQVGDSMDR-NH2

Ref. 3D-PP42865

Informations sur le produit

• Nom: Ac-EDIIRNIARHLAQVGDSMDR-NH2
• Synonymes: Ac-Glu-Asp-Ile-Ile-Arg-Asn-Ile-Ala-Arg-His-Leu-Ala-Gln-Val-Gly-Asp-Ser-Met-Asp-Arg-amide

Description

Peptide Ac-EDIIRNIARHLAQVGDSMDR-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-EDIIRNIARHLAQVGDSMDR-NH2 include the following: Design, Synthesis, and Interaction Study of Quinazoline-2(1H)-thione Derivatives as Novel Potential Bcl-xL Inhibitors Y Feng , X Ding, T Chen, L Chen, F Liu - Journal of medicinal , 2010 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/jm901004c A conserved hydrophobic core at Bcl-xL mediates its structural stability and binding affinity with BH3-domain peptide of pro-apoptotic protein Y Feng , L Zhang , T Hu, X Shen, J Ding, K Chen - Archives of biochemistry , 2009 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0003986109000022 Isochamaejasmin induces apoptosis in leukemia cells through inhibiting Bcl-2 family proteins SD Zhang, S Lei, LI Wei, LI Hong-Lin - Chinese journal of natural , 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1875536415300637 Jacarelhyperol A induced apoptosis in leukaemia cancer cell through inhibition the activity of Bcl-2 proteins S Zhang, J Yin, X Li, J Zhang, R Yue, Y Diao, H Li - BMC cancer, 2014 - Springerhttps://link.springer.com/article/10.1186/1471-2407-14-689 Solution structure of the BHRF1 protein from Epstein-Barr virus, a homolog of human Bcl-2 Q Huang, AM Petros, HW Virgin , SW Fesik - Journal of molecular , 2003 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022283603010234 Diversity Oriented Synthesis, Characterization and Anti-Cancer Activity of Killer Peptide Nucleolipid Bioconjugates NK Rana - 2017 - search.proquest.comhttps://search.proquest.com/openview/c71358671108c8599684fb2e5765817b/1?pq-origsite=gscholar&cbl=18750 Bcl-2 is a critical mediator of intestinal transformation M Van Der Heijden, CD Zimberlin - Nature , 2016 - nature.comhttps://www.nature.com/articles/ncomms10916 Toward intracellular targeted delivery of cancer therapeutics: progress and clinical outlook for brain tumor therapy H Pandya, W Debinski - BioDrugs, 2012 - Springerhttps://link.springer.com/article/10.1007/BF03261882 Comparison of chemical inhibitors of antiapoptotic Bcl-2-family proteins D Zhai, C Jin, AC Satterthwait, JC Reed - Cell Death & Differentiation, 2006 - nature.comhttps://www.nature.com/articles/4401937 A Novel Membrane-Permeable Breast-Targeting Pro-Apoptotic Peptide for Treatment of Breast Cancer B Guo, NORTH DAKOTA STATE UNIV FARGO - 2005 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/tr/ADA474733 REPORT DOCUMENTATION PAGE OIMB No. 0704-0188 B Guo - 2005 - Citeseerhttps://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=9bb8c17e31993e0a9ecc5daef286c89b42e94acc

• Marque: Biosynth